{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T01:49:55Z","timestamp":1775180995064,"version":"3.50.1"},"reference-count":72,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006920","name":"University of Pennsylvania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018232","name":"University of Pennsylvania The Orphan Disease Center","doi-asserted-by":"publisher","award":["MDBR-24-016-APBD"],"award-info":[{"award-number":["MDBR-24-016-APBD"]}],"id":[{"id":"10.13039\/100018232","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ajpath.2025.11.006","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:03:12Z","timestamp":1765843392000},"page":"731-744","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Systemic Disease Progression and Neurodegeneration in the Gbe1 Mouse Model of Glycogen Storage Disease Type IV"],"prefix":"10.1016","volume":"196","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7681-6493","authenticated-orcid":false,"given":"Su Jin","family":"Choi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca L.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4435-6853","authenticated-orcid":false,"given":"Rebecca A.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8219-4326","authenticated-orcid":false,"given":"Fiona E.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yadav","family":"Adhikari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Eisner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aarav","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William R.","family":"Jeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4373-4800","authenticated-orcid":false,"given":"Jeong-A","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8251-909X","authenticated-orcid":false,"given":"Priya S.","family":"Kishnani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2025.11.006_bib1","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0022-3476(71)80466-3","article-title":"Type IV glycogen storage disease: branching enzyme deficiency in skin fibroblasts and possible heterozygote detection","volume":"78","author":"Howell","year":"1971","journal-title":"J Pediatr"},{"key":"10.1016\/j.ajpath.2025.11.006_bib2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1432-1033.1991.tb16225.x","article-title":"The discovery of glycogenin and the priming mechanism for glycogen biogenesis","volume":"200","author":"Smythe","year":"1991","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.ajpath.2025.11.006_bib3","doi-asserted-by":"crossref","first-page":"5667","DOI":"10.1093\/hmg\/ddv280","article-title":"Structural basis of glycogen branching enzyme deficiency and pharmacologic rescue by rational peptide design","volume":"24","author":"Froese","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ajpath.2025.11.006_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2023.107525","article-title":"Diagnosis and management of glycogen storage disease type IV, including adult polyglucosan body disease: a clinical practice resource","volume":"138","author":"Koch","year":"2023","journal-title":"Mol Genet Metab"},{"issue":"Suppl 3","key":"10.1016\/j.ajpath.2025.11.006_bib5","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1007\/s10545-009-9026-5","article-title":"Glycogen storage disease type IV: novel mutations and molecular characterization of a heterogeneous disorder","volume":"33","author":"Li","year":"2010","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.ajpath.2025.11.006_bib6","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/0883073807309248","article-title":"A case of congenital glycogen storage disease type IV with a novel GBE1 mutation","volume":"23","author":"Raju","year":"2008","journal-title":"J Child Neurol"},{"key":"10.1016\/j.ajpath.2025.11.006_bib7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.5114\/aoms.2018.72246","article-title":"Variable clinical presentation of glycogen storage disease type IV: from severe hepatosplenomegaly to cardiac insufficiency. Some discrepancies in genetic and biochemical abnormalities","volume":"14","author":"Szyma\u0144ska","year":"2018","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.ajpath.2025.11.006_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.992406","article-title":"A novel approach to characterize phenotypic variation in GSD IV: reconceptualizing the clinical continuum","volume":"13","author":"Kiely","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.ajpath.2025.11.006_bib9","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1007\/s00415-022-10960-z","article-title":"Characterization of cognitive impairment in adult polyglucosan body disease","volume":"269","author":"Zebhauser","year":"2022","journal-title":"J Neurol"},{"key":"10.1016\/j.ajpath.2025.11.006_bib10","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1172\/JCI118517","article-title":"Hepatic and neuromuscular forms of glycogen storage disease type IV caused by mutations in the same glycogen-branching enzyme gene","volume":"97","author":"Bao","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2025.11.006_bib11","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.gene.2012.12.065","article-title":"Abnormal glycogen in astrocytes is sufficient to cause adult polyglucosan body disease","volume":"515","author":"Dainese","year":"2013","journal-title":"Gene"},{"key":"10.1016\/j.ajpath.2025.11.006_bib12","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/ana.410440604","article-title":"Adult polyglucosan body disease in Ashkenazi Jewish patients carrying the Tyr(329)Ser mutation in the glycogen-branching enzyme gene","volume":"44","author":"Lossos","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ajpath.2025.11.006_bib13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/brain\/103.2.315","volume":"103","author":"Robitaille","year":"1980","journal-title":"Brain"},{"key":"10.1016\/j.ajpath.2025.11.006_bib14","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.4065\/75.12.1327","article-title":"Probable adult polyglucosan body disease","volume":"75","author":"Klein","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ajpath.2025.11.006_bib15","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/ana.23598","article-title":"Adult polyglucosan body disease: natural history and key magnetic resonance imaging findings","volume":"72","author":"Mochel","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ajpath.2025.11.006_bib16","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.nmd.2023.03.010","article-title":"Novel brain MRI clues to diagnose adult polyglucosan body disease\u2014a commentary","volume":"33","author":"Mochel","year":"2023","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ajpath.2025.11.006_bib17","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.177722","article-title":"Natural history study of hepatic glycogen storage disease type IV and comparison to Gbe1ys\/ys model","volume":"9","author":"Koch","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.ajpath.2025.11.006_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2023.1282790","article-title":"Case report: expanding the understanding of the adult polyglucosan body disease continuum: novel presentations, diagnostic pitfalls, and clinical pearls","volume":"14","author":"Gayed","year":"2023","journal-title":"Front Genet"},{"key":"10.1016\/j.ajpath.2025.11.006_bib19","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1093\/hmg\/ddr371","article-title":"Generation of a novel mouse model that recapitulates early and adult onset glycogenosis type IV","volume":"20","author":"Akman","year":"2011","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ajpath.2025.11.006_bib20","doi-asserted-by":"crossref","first-page":"6801","DOI":"10.1093\/hmg\/ddv385","article-title":"A novel mouse model that recapitulates adult-onset glycogenosis type 4","volume":"24","author":"Akman","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ajpath.2025.11.006_bib21","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1002\/acn3.51211","article-title":"GYS1 or PPP1R3C deficiency rescues murine adult polyglucosan body disease","volume":"7","author":"Chown","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.ajpath.2025.11.006_bib22","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1089\/hum.2016.099","article-title":"Systemic correction of murine glycogen storage disease type IV by an AAV-mediated gene therapy","volume":"28","author":"Yi","year":"2017","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.ajpath.2025.11.006_bib23","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1007\/s13311-021-01040-7","article-title":"Targeting Gys1 with AAV-SaCas9 decreases pathogenic polyglucosan bodies and neuroinflammation in adult polyglucosan body and Lafora disease mouse models","volume":"18","author":"Gumusgoz","year":"2021","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ajpath.2025.11.006_bib24","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1007\/s13311-022-01218-7","article-title":"AAV-mediated artificial miRNA reduces pathogenic polyglucosan bodies and neuroinflammation in adult polyglucosan body and lafora disease mouse models","volume":"19","author":"Gumusgoz","year":"2022","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ajpath.2025.11.006_bib25","first-page":"31","article-title":"Alglucosidase alfa treatment alleviates liver disease in a mouse model of glycogen storage disease type IV","volume":"9","author":"Yi","year":"2016","journal-title":"Mol Genet Metab Rep"},{"key":"10.1016\/j.ajpath.2025.11.006_bib26","first-page":"89","article-title":"A modified enzymatic method for measurement of glycogen content in glycogen storage disease type IV","volume":"30","author":"Yi","year":"2016","journal-title":"JIMD Rep"},{"key":"10.1016\/j.ajpath.2025.11.006_bib27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.omtm.2019.01.006","article-title":"Intravenous injection of an AAV-PHP.B vector encoding human acid [alpha]-glucosidase rescues both muscle and CNS defects in murine Pompe disease","volume":"12","author":"Lim","year":"2019","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.ajpath.2025.11.006_bib28","first-page":"54052","article-title":"The treadmill fatigue test: a simple, high-throughput assay of fatigue-like behavior for the mouse","volume":"31","author":"Dougherty","year":"2016","journal-title":"J Vis Exp"},{"key":"10.1016\/j.ajpath.2025.11.006_bib29","first-page":"2610","article-title":"Measuring the strength of mice","author":"Deacon","year":"2013","journal-title":"J Vis Exp"},{"key":"10.1016\/j.ajpath.2025.11.006_bib30","first-page":"2376","article-title":"Assessment of motor balance and coordination in mice using the balance beam","author":"Luong","year":"2011","journal-title":"J Vis Exp"},{"key":"10.1016\/j.ajpath.2025.11.006_bib31","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/BF02246955","article-title":"Quantitative grip strength assessment as a means of evaluating muscle relaxation in mice","volume":"110","author":"Nevins","year":"1993","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ajpath.2025.11.006_bib32","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1093\/hmg\/ddn117","article-title":"Analysis of cerebellar function in Ube3a-deficient mice reveals novel genotype-specific behaviors","volume":"17","author":"Heck","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ajpath.2025.11.006_bib33","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G\u2217Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav Res Methods"},{"key":"10.1016\/j.ajpath.2025.11.006_bib34","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","article-title":"Statistical power analyses using G\u2217Power 3.1: tests for correlation and regression analyses","volume":"41","author":"Faul","year":"2009","journal-title":"Behav Res Methods"},{"key":"10.1016\/j.ajpath.2025.11.006_bib35","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.neurobiolaging.2009.11.003","article-title":"Behavioral changes in aging female C57BL\/6 mice","volume":"32","author":"Fahlstr\u00f6m","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.ajpath.2025.11.006_bib36","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/jnc.12742","article-title":"Enteric GFAP expression and phosphorylation in Parkinson\u2019s disease","volume":"130","author":"Clairembault","year":"2014","journal-title":"J Neurochem"},{"key":"10.1016\/j.ajpath.2025.11.006_bib37","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/lt.21436","article-title":"Glial fibrillary acidic protein as an early marker of hepatic stellate cell activation in chronic and posttransplant recurrent hepatitis C","volume":"14","author":"Carotti","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.ajpath.2025.11.006_bib38","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1750-3639.1994.tb00838.x","article-title":"GFAP and astrogliosis","volume":"4","author":"Eng","year":"1994","journal-title":"Brain Pathol"},{"key":"10.1016\/j.ajpath.2025.11.006_bib39","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41582-021-00616-3","article-title":"Blood GFAP as an emerging biomarker in brain and spinal cord disorders","volume":"18","author":"Abdelhak","year":"2022","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.ajpath.2025.11.006_bib40","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/0269881105051524","article-title":"The mouse beam walking assay offers improved sensitivity over the mouse rotarod in determining motor coordination deficits induced by benzodiazepines","volume":"19","author":"Stanley","year":"2005","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.ajpath.2025.11.006_bib41","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12915-015-0154-0","article-title":"Quantification of gait parameters in freely walking rodents","volume":"13","author":"Mendes","year":"2015","journal-title":"BMC Biol"},{"key":"10.1016\/j.ajpath.2025.11.006_bib42","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/mus.20916","article-title":"Adult polyglucosan body disease: proton magnetic resonance spectroscopy of the brain and novel mutation in the GBE1 gene","volume":"37","author":"Massa","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ajpath.2025.11.006_bib43","first-page":"75","article-title":"Neuromuscular forms of glycogen branching enzyme deficiency","volume":"26","author":"Bruno","year":"2007","journal-title":"Acta Myol"},{"key":"10.1016\/j.ajpath.2025.11.006_bib44","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s002340000425","article-title":"Extensive white-matter changes in case of adult polyglucosan body disease","volume":"43","author":"Berkhoff","year":"2001","journal-title":"Neuroradiology"},{"key":"10.1016\/j.ajpath.2025.11.006_bib45","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/nan.12144","article-title":"Adult polyglucosan body disease with GBE1 haploinsufficiency and concomitant frontotemporal lobar degeneration","volume":"40","author":"Bit-Ivan","year":"2014","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.ajpath.2025.11.006_bib46","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3389\/fnins.2020.00579","article-title":"Neurofilament-light chain as biomarker of neurodegenerative and rare diseases with high translational value","volume":"14","author":"Loeffler","year":"2020","journal-title":"Front Neurosci"},{"key":"10.1016\/j.ajpath.2025.11.006_bib47","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1212\/WNL.0000000000001642","article-title":"Neurofilament light chain: a prognostic biomarker in amyotrophic lateral sclerosis","volume":"84","author":"Lu","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.ajpath.2025.11.006_bib48","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/jns.12279","article-title":"Serum and cerebrospinal neurofilament light chain levels in patients with acquired peripheral neuropathies","volume":"23","author":"Mariotto","year":"2018","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.ajpath.2025.11.006_bib49","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.expneurol.2018.06.005","article-title":"Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy","volume":"307","author":"Meregalli","year":"2018","journal-title":"Exp Neurol"},{"key":"10.1016\/j.ajpath.2025.11.006_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2021.689938","article-title":"Neurofilament proteins as biomarkers to monitor neurological diseases and the efficacy of therapies","volume":"15","author":"Yuan","year":"2021","journal-title":"Front Neurosci"},{"key":"10.1016\/j.ajpath.2025.11.006_bib51","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","article-title":"Neurofilament light chain as a biomarker in neurological disorders","volume":"90","author":"Gaetani","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ajpath.2025.11.006_bib52","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neuron.2016.05.018","article-title":"Neurofilament light chain in blood and CSF as marker of disease progression in mouse models and in neurodegenerative diseases","volume":"91","author":"Bacioglu","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.ajpath.2025.11.006_bib53","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neurobiolaging.2020.07.018","article-title":"Blood and cerebrospinal fluid neurofilament light differentially detect neurodegeneration in early Alzheimer\u2019s disease","volume":"95","author":"Andersson","year":"2020","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.ajpath.2025.11.006_bib54","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1212\/WNL.0000000000207482","article-title":"Neurofilament light and its association with CNS involvement in patients with classic infantile Pompe disease","volume":"101","author":"Mackenbach","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.ajpath.2025.11.006_bib55","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.gim.2022.10.005","article-title":"Evaluating brain white matter hyperintensity, IQ scores, and plasma neurofilament light chain concentration in early-treated patients with infantile-onset Pompe disease","volume":"25","author":"Hsu","year":"2023","journal-title":"Genet Med"},{"key":"10.1016\/j.ajpath.2025.11.006_bib56","article-title":"Case report: familial glycogen storage disease type IV caused by novel compound heterozygous mutations in a glycogen branching enzyme 1 gene","volume":"13","author":"Li","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.ajpath.2025.11.006_bib57","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/ajcp\/66.4.702","article-title":"Type IV glycogen-storage disease. Light-microscopic, electron-microscopic, and enzymatic study","volume":"66","author":"Bannayan","year":"1976","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ajpath.2025.11.006_bib58","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/MOH.0000000000000474","article-title":"Neutropenia in glycogen storage disease Ib: outcomes for patients treated with granulocyte colony-stimulating factor","volume":"26","author":"Dale","year":"2019","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.ajpath.2025.11.006_bib59","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1067\/mpd.2000.105232","article-title":"Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: results of the European Study on Glycogen Storage Disease type I","volume":"137","author":"Visser","year":"2000","journal-title":"J Pediatr"},{"key":"10.1016\/j.ajpath.2025.11.006_bib60","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1172\/JCI115049","article-title":"Chronic neutropenia. A new canine model induced by human granulocyte colony-stimulating factor","volume":"87","author":"Hammond","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2025.11.006_bib61","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1046\/j.1537-2995.2003.00384.x","article-title":"G-CSF-induced spleen size changes in peripheral blood progenitor cell donors","volume":"43","author":"Stroncek","year":"2003","journal-title":"Transfusion"},{"key":"10.1016\/j.ajpath.2025.11.006_bib62","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13023-025-03570-1","article-title":"Gastrointestinal complications of hepatic glycogen storage disease: a national survey questionnaire study in China","volume":"20","author":"Zhang","year":"2025","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ajpath.2025.11.006_bib63","doi-asserted-by":"crossref","DOI":"10.1172\/JCI143780","article-title":"Overcoming innate immune barriers that impede AAV gene therapy vectors","volume":"131","author":"Muhuri","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ajpath.2025.11.006_bib64","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/764286","article-title":"Cardiac involvement in glycogen storage disease type IV: two cases and the two ends of a spectrum","volume":"2012","author":"Aksu","year":"2012","journal-title":"Case Rep Med"},{"key":"10.1016\/j.ajpath.2025.11.006_bib65","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/BF00294181","article-title":"Neonatal hypotonia and cardiomyopathy secondary to type IV glycogenosis","volume":"87","author":"Tang","year":"1994","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ajpath.2025.11.006_bib66","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/GIM.0b013e3181e0e979","article-title":"Echocardiographic manifestations of glycogen storage disease III: increase in wall thickness and left ventricular mass over time","volume":"12","author":"Vertilus","year":"2010","journal-title":"Genet Med"},{"key":"10.1016\/j.ajpath.2025.11.006_bib67","first-page":"338","article-title":"An unusual presentation of metabolic cardiomyopathy due to Pompe\u2019s disease","volume":"23","author":"Venugopalan","year":"2002","journal-title":"Saudi Med J"},{"key":"10.1016\/j.ajpath.2025.11.006_bib68","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejim.2007.09.018","article-title":"Cardiomyopathy in Pompe\u2019s disease","volume":"19","author":"Fayssoil","year":"2008","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.ajpath.2025.11.006_bib69","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1515\/JPEM.2009.22.12.1159","article-title":"Enzyme replacement therapy in an infant with Pompe\u2019s disease with severe cardiomyopathy","volume":"22","author":"Tanzer","year":"2009","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.ajpath.2025.11.006_bib70","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.omtm.2020.05.034","article-title":"A novel gene therapy approach for GSD III using an AAV vector encoding a bacterial glycogen debranching enzyme","volume":"18","author":"Lim","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.ajpath.2025.11.006_bib71","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3390\/biomedicines11020363","article-title":"A broad characterization of glycogen storage disease IV patients: a clinical, genetic, and histopathological study","volume":"11","author":"Wilke","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.ajpath.2025.11.006_bib72","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.nmd.2014.11.006","article-title":"A novel GBE1 mutation and features of polyglucosan bodies autophagy in adult polyglucosan body disease","volume":"25","author":"Sampaolo","year":"2015","journal-title":"Neuromuscul Disord"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944025004377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944025004377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T01:10:04Z","timestamp":1775178604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944025004377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0002944025004377"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2025.11.006","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic Disease Progression and Neurodegeneration in the Gbe1ys\/ys Mouse Model of Glycogen Storage Disease Type IV","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2025.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Investigative Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}